Fraisinib is a specific and effective ингибитор of glycyl-tRNA synthetase 1 (GARS1), suppresses the synthesis of Ap4A by GARS1 and displays strong anti-tumoral potential.
Fraisinib is a specific and effective inhibitor of glycyl-tRNA synthetase 1 (GARS1), suppresses the synthesis of Ap4A by GARS1 and displays strong anti-tumoral potential.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.